Tag: Roflumilast Accord

Roflumilast Accord – Roflumilast uses, dose and side effects

Roflumilast Accord contains the active substance roflumilast which is an anti-inflammatory agent called phosphodiesterase ‑4 ‑ inhibitor. Roflumilast reduces the activity of phosphodiesterase ‑4, a protein that occurs naturally in the body’s cells. When the activity of this protein is reduced, inflammation in the lungs decreases. This helps to stop the narrowing of the airways that occurs in chronic obstructive pulmonary disease (COPD). Roflumilast Accord thus relieves breathing problems.

Read More